Chemical Formula: C16H23NO7
Chemical Formula C16H23NO7
Found 16 metabolite its formula value is C16H23NO7
Mycotoxin T 2
Isolated from seed pods of Moringa oleifera (horseradish tree). Mycotoxin T 2 is found in fats and oils, herbs and spices, and green vegetables. Mycotoxin T 2 is found in fats and oils. Mycotoxin T 2 is a mycotoxin T 2 is isolated from seed pods of Moringa oleifera (horseradish tree)
Monocrotaline N-Oxide
CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 173 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 163 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 153 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 143 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 133 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 123 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 113 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 103 INTERNAL_ID 103; CONFIDENCE Reference Standard (Level 1)
6,7-dihydroxy-1-methyl-N-(6-fructopyranosyl)-1,2,3,4-tetrahydroisoquinoline
Monocrotaline N-Oxide
Monocrotaline N-Oxide, a monocrotaline metabolite, leads to DNA adduct formation in vivo. Monocrotaline N-Oxide is a derivative of monocrotaline, which is a pyrrolizidine alkaloid. Pyrrolizidine alkaloids are a class of naturally occurring compounds found in various plants. Monocrotaline itself is known for its toxic effects, particularly its ability to cause liver damage and pulmonary hypertension in animals. The biological functions and effects of Monocrotaline N-Oxide are primarily studied in the context of its toxicology and pharmacology: Metabolic Activation: Monocrotaline N-Oxide is a metabolite of monocrotaline. In biological systems, monocrotaline is metabolized to its N-oxide form, which can then be further converted into reactive intermediates that can form DNA adducts, leading to potential mutagenicity and carcinogenicity. Toxicity: Like monocrotaline, Monocrotaline N-Oxide is toxic, particularly to the liver and lungs. It can induce pulmonary hypertension, a condition characterized by increased blood pressure in the arteries of the lungs. This makes it useful in animal models to study the pathophysiology of this disease. Research Tool: Due to its toxic effects, Monocrotaline N-Oxide is used in research as a tool to investigate the mechanisms of toxin-induced liver and lung damage, as well as to study the biological pathways involved in the metabolism and detoxification of pyrrolizidine alkaloids. Potential Therapeutic Uses: Although highly toxic, monocrotaline and its derivatives have been studied for their potential therapeutic uses, particularly in the context of cancer treatment, due to their ability to damage rapidly dividing cells. Ecological Role: In nature, pyrrolizidine alkaloids like monocrotaline may serve as defense mechanisms for plants, deterring herbivory due to their toxic properties. It's important to note that while Monocrotaline N-Oxide has significant biological effects, its use is largely restricted to research settings due to its toxicity. Handling and use of this compound require strict safety precautions to prevent exposure and adverse health effects.
C16H23NO7_2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione, 4,5,8,10,12,13,13a,13b-octahydro-3,4-dihydroxy-3,4,5-trimethyl-, 11-oxide
(4S,5Z,6S)-4-(2-methoxy-2-oxoethyl)-5-[2-[(E)-3-phenylprop-2-enoyl]oxyethylidene]-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylic acid
Phendimetrazine tartrate
D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant C78272 - Agent Affecting Nervous System > C29728 - Anorexiant
n-({4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]phenyl}methyl)ethoxycarboximidic acid
6,7-dihydroxy-1-methyl-n-(6'-fructopyranosyl)-1,2,3,4-tetrahydroisoquinoline
{"Ingredient_id": "HBIN012063","Ingredient_name": "6,7-dihydroxy-1-methyl-n-(6'-fructopyranosyl)-1,2,3,4-tetrahydroisoquinoline","Alias": "NA","Ingredient_formula": "C16H23NO7","Ingredient_Smile": "CC1C2=CC(=C(C=C2CCN1C3(C(C(C(CO3)O)O)O)CO)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6032","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
